Products for Research Use Only

Enapotamab vedotin

CAT: 0804-HY-P99921Size: 1 EachDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99921Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC). Enapotamab vedotin also exhibits resistant to EGFR inhibitor such as Osimertinib.
CAS Number
1912424-97-5
Product Name Alternative
HuMax-AXL-ADC
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; TAM Receptor
Related Pathways
Antibody-drug Conjugate/ADC Related; Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Enapotamabvedotin]
References & Citations
[1]Koopman LA, et al. Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer. JCI Insight. 2019 Nov 1;4 (21) :e128199.
Shipping Conditions
Dry Ice
Scientific Category
ADC Related
Clinical Information
Phase 2